# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-24-000036
Filing Date
2024-10-31
Accepted
2024-10-30 19:13:33
Documents
118
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bhc-20240930.htm iXBRL | 10-Q | 2776937
2 | EX-10.1 | exhibit101q32024.htm | EX-10.1 | 179609
3 | EX-10.2 | exhibit102q32024.htm | EX-10.2 | 8863
4 | EX-31.1 | exhibit311q32024.htm | EX-31.1 | 10088
5 | EX-31.2 | exhibit312q32024.htm | EX-31.2 | 10135
6 | EX-32.1 | exhibit321q32024.htm | EX-32.1 | 6575
7 | EX-32.2 | exhibit322q32024.htm | EX-32.2 | 6508
13 | GRAPHIC | image_0a.jpg | GRAPHIC | 107987
| Complete submission text file | 0000885590-24-000036.txt |  | 13999213

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bhc-20240930.xsd | EX-101.SCH | 99728
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bhc-20240930_cal.xml | EX-101.CAL | 94441
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bhc-20240930_def.xml | EX-101.DEF | 566719
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bhc-20240930_lab.xml | EX-101.LAB | 895595
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bhc-20240930_pre.xml | EX-101.PRE | 747668
121 | EXTRACTED XBRL INSTANCE DOCUMENT | bhc-20240930_htm.xml | XML | 2438108

Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 241411897
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)